- Home
- MRP vs IRTC Comparison
MRP vs IRTC Comparison
Compare MRP & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRP
- IRTC
- Stock Information
- Founded
- MRP N/A
- IRTC 2006
- Country
- MRP United States
- IRTC United States
- Employees
- MRP N/A
- IRTC N/A
- Industry
- MRP
- IRTC Medical/Dental Instruments
- Sector
- MRP
- IRTC Health Care
- Exchange
- MRP NYSE
- IRTC Nasdaq
- Market Cap
- MRP 4.1B
- IRTC 4.5B
- IPO Year
- MRP N/A
- IRTC 2016
- Fundamental
- Price
- MRP $28.27
- IRTC $145.74
- Analyst Decision
- MRP Strong Buy
- IRTC Strong Buy
- Analyst Count
- MRP 2
- IRTC 10
- Target Price
- MRP $30.75
- IRTC $138.60
- AVG Volume (30 Days)
- MRP 755.7K
- IRTC 457.7K
- Earning Date
- MRP 08-18-2025
- IRTC 07-31-2025
- Dividend Yield
- MRP 3.76%
- IRTC N/A
- EPS Growth
- MRP N/A
- IRTC N/A
- EPS
- MRP N/A
- IRTC N/A
- Revenue
- MRP $82,698,000.00
- IRTC $618,587,000.00
- Revenue This Year
- MRP N/A
- IRTC $19.91
- Revenue Next Year
- MRP N/A
- IRTC $16.81
- P/E Ratio
- MRP N/A
- IRTC N/A
- Revenue Growth
- MRP N/A
- IRTC 20.54
- 52 Week Low
- MRP $21.02
- IRTC $55.92
- 52 Week High
- MRP $28.99
- IRTC $150.00
- Technical
- Relative Strength Index (RSI)
- MRP N/A
- IRTC 63.44
- Support Level
- MRP N/A
- IRTC $141.19
- Resistance Level
- MRP N/A
- IRTC $146.90
- Average True Range (ATR)
- MRP 0.00
- IRTC 3.50
- MACD
- MRP 0.00
- IRTC -1.09
- Stochastic Oscillator
- MRP 0.00
- IRTC 63.96
About MRP MILLROSE PROPERTIES INC.
Millrose Properties Inc is a Holding Company. The company along with its subsidiaries engages in providing operational and capital solutions for home builders and land development companies to finance the acquisition and development of land assets through its Homesite Option Purchase Platform.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.